ECIL Committee Updates Antifungal Prophylaxis Guidelines for MDS, ALL, and CLL

Retrieved on: 2025-05-29 13:26:36

Tags for this article:

Click the tags to see associated articles and topics

ECIL Committee Updates Antifungal Prophylaxis Guidelines for MDS, ALL, and CLL. View article details on hiswai:

Excerpt

Monoclonal antibodies such as blinatumomab and inotuzumab ozogamicin have not been linked to an increased risk of IFD. Triazoles (especially ...

Article found on: www.hematologyadvisor.com